From operational support to strategic innovation, discover how India's GCCs are reshaping healthcare and life sciences.
India’s Global Capability Centers are evolving from operational support hubs into strategic engines of innovation across healthcare and life sciences.
Global healthcare organizations including Bayer, Roche, Johnson & Johnson, AstraZeneca, Novo Nordisk, and Thermo Fisher Scientific are expanding their GCC presence in India, building capabilities across clinical research, AI, digital health, regulatory strategy, and data science. This shift reflects a broader transformation in how global organizations approach innovation, with GCCs increasingly contributing to research, technology development, and business strategy.
India’s growing role in this ecosystem is supported by a combination of healthcare and life sciences talent, strong engineering and digital capabilities, a supportive business environment, increasing global healthcare investment, and expanding research and technology infrastructure.
As organizations move beyond building larger teams toward developing specialized capabilities, the next generation of healthcare GCCs will play an increasingly strategic role in shaping global innovation.
Explore how India’s GCC ecosystem is evolving and why its next phase could be one of the defining shifts in healthcare and life sciences.
Join the conversation at RISE Health Innovation Summit 2026, where industry leaders will explore how GCCs are shaping the future of healthcare and life sciences.
#GlobalCapabilityCenters #GCC #HealthcareGCC #LifeSciences #HealthcareInnovation #IndiaGCC #GCCIndia #DigitalHealth #AI #ClinicalResearch #DataScience #HealthcareTechnology #BusinessStrategy #Healthark #RISE2026










